Novartis Pharmaceuticals Corporation
Recent News About Novartis Pharmaceuticals Corporation View More
-
U.S. District Court for the Western District of Pennsylvania: Actions Taken on March 27
The U.S. District Court for the Western District of Pennsylvania reported the following activity on March 27 in the suits below: -
U.S. District Court for the Western District of Pennsylvania: Actions Taken on March 26
The U.S. District Court for the Western District of Pennsylvania reported the following activity on March 26 in the suits below: -
Court activity on March 26: Anthony Buzzelli vs Novartis Pharmaceuticals Corp.
The U.S. District Court for the Western District of Pennsylvania reported the following activity in the suit brought by Anthony Buzzelli and Lorraine Buzzelli against Novartis Pharmaceuticals Corp. on March 26: 'Complaint Against Novartis Pharmaceuticals Corporation (filing Fee, Including Administrative Fee, $400, Receipt Number 0315-5527693), Filed By Anthony Buzzelli, Lorraine Buzzelli. (attachments: # 1 Civil Cover Sheet, # 2 Summons) (ept)'. -
Case activity for Anthony Buzzelli vs Novartis Pharmaceuticals Corp. on March 27
The U.S. District Court for the Western District of Pennsylvania reported the following activities in the suit brought by Anthony Buzzelli and Lorraine Buzzelli against Novartis Pharmaceuticals Corp. on March 27. -
Court: 'Speculation' insufficient to overturn summary judgment to Novartis Pharmaceuticals
PHILADELPHIA – A federal appeals court has decided summary judgment was correctly granted in the case of a cancer patient who contracted osteonecrosis of the jaw (ONJ) in response to a medication he was administered.